Nihal ÇETİN YURTERİ, İbrahim Ethem ŞAHİN

Decreased serum levels of total and high molecular weight adiponectin in treatment-naïve children with ADHD

Objective: Attention deficit hyperactivity disorder (ADHD) is considered to be one of the most common childhood psychiatric disorders. The aim of this study was to examine serum levels of total and High Molecular Weight (HMW)adiponectin, and also HMW/total adiponectin ratio with respect to ADHD symptomatology in children. Methods: Serum levels of total adiponectin and HMW adiponectin were measured by commercial enzyme-linked immunesorbent assay kits in 44 treatment-naïve children with ADHD and age, gender matched 44 healthy controls. ADHD symptoms were scored by Conners’ Parent Rating Scale-Revised Short (CPRS-RS) and ADHD Rating Scale (ADHD-RS). Body Mass Index-Standart Deviation Scores (BMI-SDS) of all children were evaluated. Results: There were no significant difference in terms of gender, age and BMI-SDS between ADHD and healthy control groups (respectively, p=1, p=0.475, p=0.097). We found that serum total, HMW adiponectin levels and HMW adiponectin/ total adiponectin ratio were significantly lower in ADHD group compared to controls (p

Dikkat eksikliği hiperaktivite bozukluğu olan çocuklarda serum toplam ve yüksek moleküler ağırlıklı adiponektin düzeyleri

Amaç: Dikkat eksikliği hiperaktivite bozukluğu (DEHB), en sık görülen çocukluk çağı psikiyatrik bozukluklarından biri olarak kabul edilir. Bu çalışmanın amacı, DEHB’li çocuklarda, toplam ve yüksek moleküler ağırlıklı (YMA) adiponektin serum düzeylerini, YMA/toplam adiponektin oranını ve bu parametrelerle DEHB belirtileri arasındaki ilişkiyi incelemektir. Yöntem: DEHB tanısını yeni konmuş 44 çocuk ve yaş, cinsiyet açısından DEHB grubuyla eşleştirilmiş 44 sağlıklı çocukta, toplam adiponektin ve YMA adiponektinin serum düzeyleri, enzim bağlı immünosorban test kitleri (ELISA) ile ölçülmüştür. Tüm çocuklarda, DEHB belirtileri Conners Ebeveyn Derecelendirme Ölçeği-Yenilenmiş Kısa (CPRS-RS) ve DEHB Derecelendirme Ölçeği (ADHD-RS) ile değerlendirilmiştir. Beden kitle indeksi standart sapma puanları (BMI-SDS) hesaplanmıştır. Sonuçlar: DEHB ve sağlıklı kontrol grupları arasında cinsiyet, yaş ve BMI-SDS açısından anlamlı fark bulunmadı (sırayla, p=1, p=0.475, p=0.097). Serum toplam, YMA adiponektin düzeyleri ve YMA adiponektin/toplam adiponektin oranının, DEHB grubunda kontrollere göre anlamlı olarak düşük olduğu bulundu (p

PDF

___

1. Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry 2015; 56(3):345-365.

2. Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 2014; 43(2):434-442.

3. Albayrak O, Friedel S, Schimmelmann BG, Hinney A, Hebebrand J. Genetic aspects in attentiondeficit/hyperactivity disorder. J Neural Transm (Vienna) 2008; 115(2):305-315.

4. Hoekstra PJ. Towards a better understanding of the many facets of attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry 2018; 27:261-262.

5. Schuch V, Utsumi DA, Costa TV, Kulikowski LD, Muszkat M. Attention deficit hyperactivity disorder in the light of the epigenetic paradigm. Front Psychiatry 2015; 6:126.

6. Cortese S, Moreira-Maia CR, St Fleur D, MorcilloPeñalver C, Rohde LA, Faraone SV. Association between ADHD and obesity: a systematic review and meta-analysis. Am J Psychiatry 2016; 173(1): 34-43.

7. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278(41):40352- 40363.

8. Ozarda Y, Tuncer GO, Gunes Y, Eroz E. Serum levels of leptin, adiponectin and resistin are interrelated and related to total antioxidant capacity, free fatty acids and phospholipids in early neonatal life. Clin Biochem 2012; 45(4-5):298-302.

9. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007; 380(1-2):24- 30.

10. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 2010; 285(9):6153-6160.

11. Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF. Adiponectin action from head to toe. Endocrine 2010; 37(1):11-32.

12. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin--a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8(3):264-280.

13. Thundyil J, Pavlovski D, Sobey CG, Arumugam TV. Adiponectin receptor signalling in the brain. Br J Pharmacol 2012; 165(2):313-327.

14. Fujita-Shimizu A, Suzuki K, Nakamura K, Miyachi T, Matsuzaki H, Kajizuka M, et al. Decreased serum levels of adiponectin in subjects with autism. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34(3):455-458.

15. Mavroconstanti T, Halmøy A, Haavik J. Decreased serum levels of adiponectin in adult attention deficit hyperactivity disorder. Psychiatry Res 2014; 216(1):123-130.

16. Morisaki H, Yamanaka I, Iwai N, Miyamoto Y, Kokubo Y, Okamura T, et al. CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat 2012; 33(2):402-410.

17. Wu Y, Li Y, Lange EM, Croteau-Chonka DC, Kuzawa CW, McDade TW, et al. Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet 2010; 19(24):4955-4964.

18. Özcan Ö, Arslan M, Güngör S, Yüksel T, Selimoğlu MA. Plasma leptin, adiponectin, neuropeptide y levels in drug naive children with ADHD. J Atten Disord 2018; 22(9):896-900.

19. Sahin S, Yuce M, Alacam H, Karabekiroglu K, Say GN, Salıs O. Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder. Int J Psychiatry Clin Pract 2014; 18(4):280-287.

20. Torabi F, Farahani A, Safakish S, Ramezankhani A, Dehghan F. Evaluation of motor proficiency and adiponectin in adolescent students with attention deficit hyperactivity disorder after high-intensity intermittent training. Psychiatry Res 2018; 261:40- 44.

21. Neyzi O, Bundak R, Gökçay G, Günöz H, Furman A, Darendeliler F, et al. Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol 2015; 7(4):280-293.

22. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44(1):45-60.

23. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36(7):980-988.

24. Gökler B, Ünal F, Pehlivantürk B, Çengel-Kültür E, Akdemir D, Taner Y. The reliability and validity of the Turkish Version of Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version for School Children. Turk J Child Adolesc Ment Health 2004; 11(3):109-116.

25. Ünal F, Öktem F, Çetin Çuhadaroğlu F, Çengel Kültür SE, Akdemir D, Foto Özdemir D, et al. Reliability and validity of the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version, DSM-5 November 2016-Turkish adaptation (K-SADS-PLDSM-5-T). Turk Psikiyatri Derg 2019; 30(1):42-50.

26. Conners CK, Sitarenios G, Parker JD, Epstein JN. The revised Conners’ Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 1998; 26(4):257- 268.

27. Kaner Ş, Büyüköztürk Ş, İşeri E. Conners parent rating scale-revised short: Turkish standardization study. Arch Neuropsychiatr 2013; 50:100-109.

28. Dupaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale IV: Checklists, Norms and Clinical Interpretation. New York (NY): Guilford Press, 1998.

29. Akay AP, Resmi H, Güney SA, Erkuran HÖ, Özyurt G, Sargin E, et al. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study. Eur Child Adolesc Psychiatry 2018; 27(1):127-135.

30. Yurteri N, Şahin İE, Tufan AE. Altered serum levels of vascular endothelial growth factor and glial-derived neurotrophic factor but not fibroblast growth factor-2 in treatment-naive children with attention deficit/hyperactivity disorder. Nord J Psychiatry 2019; 73(4-5):302-307.

31. Soares AF, Guichardant M, Cozzone D, BernoudHubac N, Bouzaïdi-Tiali N, Lagarde M, et al. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med 2005; 38(7):882-889.

32. Bonvicini C, Faraone SV, Scassellati C. Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder. World J Biol Psychiatry 2018; 19(2):80-100.

33. Schulz C, Paulus K, Lehnert H. Adipocyte-brain: crosstalk. Results Probl Cell Differ 2010; 52:189- 201.

34. Song J, Kang SM, Kim E, Song HT, Lee JE. Adiponectin receptor-mediated signaling ameliorates cerebral cell damage and regulates the neurogenesis of neural stem cells at high glucose concentrations: an in vivo and in vitro study. Cell Death Dis 2015; 6(8):e1844.

35. Anand D, Colpo GD, Zeni G, Zeni CP, Teixeira AL. Attention-deficit/hyperactivity disorder and inflammation: what does current knowledge tell us? A systematic review. Front Psychiatry 2017; 8:228.

36. Hoekstra PJ. Attention-deficit/hyperactivity disorder: is there a connection with the immune system? Eur Child Adolesc Psychiatry 2019; 28(5): 601-602.

37. Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 2012; 8(9):1254-1266.

38. Darwish AH, Elgohary TM, Nosair NA. Serum interleukin-6 level in children with attention-deficit hyperactivity disorder (ADHD). J Child Neurol 2019; 34(2):61-67.

39. Cortese S, Angriman M, Comencini E, Vincenzi B, Maffeis C. Association between inflammatory cytokines and ADHD symptoms in children and adolescents with obesity: A pilot study. Psychiatry Res 2019; 278:7-11.

40. Nakamura K, Fuster JJ, Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol 2014; 63(4):250-259.